Dr. Michael John Gill

University Position

Clinical Interests

Research Interests

Graduating Year

University of Birmingham, Birmingham, England, 1976

Residency/Fellowship

Recent Publications

  1. Andrews, C.N., Gill, M.J., Urbanski, S.J., Stewart, D., Perini, R., Beck, P. Changing Epidemiology and Risk Factors for Gastrointestinal Non-Hodgkins Lymphoma in a North American Population: Population-Based Study. American Journal of Gastroenterology. 2008. In Press.
  2. van Marle, G., Gill, M.J., Kolodka, D., McManus, L., Grant, T., Church, D.L. Compartmentalization of the gut viral reservoir in HIV-1 infected patients. Retrovirology. 2008. In Press.
  3. Worthington, C.A., Gill, M.J. Participation in HIV Research: The Importance of Clinic Contact Factors. AIDS Patient Care and STDs. 2008. In Press.
  4. Loutfy, M.R., Raboud, J.M., Montaner, J.S.G., Antoniou ,T., Wynohoven, B., Smaill, F., Rouleau, D., Gill, M.J., Schlech, W., Brumme, Z.L., Mo, T., Gough, K., Rachlis, A., Harrigan, P.R., Walmsley, S.L. Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with viral failure on enfuvirtide. Antiviral Research. 2007. In Press.
  5. Sivakumaran, H., Wang, B., Gill, M.J., Beckholdt, B., Saksena, N.K., Harrich, D. Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort. Virology Journal. 2007; 4 (107): published online.
  6. The Antiretroviral Therapy (ART) Cohort Collaboration. Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1 Infected Patients. JAIDS. 2007; 46 (5): 607-615 (Dr. Gill is a member of the ART Cohort Collaboration writing and study group).
  7. Kim, J., Beckthold, B., Chen, Z., Mihowich, J., Malloch, L., Gill, M.J. 2007. Identification of a Novel HIV-1 Subtype H/J Recombinant in Canada with Discordant HIV Viral Load (RNA) Values in Three Different Commercial Assays. AIDS Research and Human Retroviruses. 2007; 23 (11): 1309-1313
  8. Hammond, E., Almeida, C-A., Mamotte, C., Nolan, D., Phillips, E., Schollaardt, T.A., Gill, M.J., Angel, J.B., Neurath, D., Li, J., Giulivi, T., McIntyre, C., Koultchitski, G., Wong, B., Reis, M., Rachlis, A., Cole, D.E., Chew, C.B., Neifer, S., Lalonde, R., Roger, M., Jeanneau, A., Mallal, S. 2007. External quality assessment of HLA-B*5701 reporting: an international multicentre survey. Antiviral Therapy. 2007; 12: 1027-1032
  9. Krentz, H.B., Siemieniuk, R., Gill, M.J. 2007. Similar Challenges with Retention in Care Issues. Clinical Infectious Diseases. 2007; 45 (11): 1527
  10. Parkins, M.D., Fonseca, K., Peets, A.D., Laupland, K.B., Shamseddin, K., Gill, M.J. 2007. Potentially Vaccine Preventable Serious Influenza Infection in an Unimmunized Pregnant Patient. Canadian Medical Association Journal. 2007; 177 (8): 851-853
  11. Levy, R., Pitout, J. Long, P., Gill, M.J. 2007. Late Presentation of Cryptococcus gattii meningitis in Traveler to Vancouver Island: A Case Report. Can J Infect Dis. 2007. 18 (3): 197-199.
  12. Are Defective in HIV Patients. Blood. 2007;109(5):2049-2057